Format
Sort by

Send to

Choose Destination

See Gene information for diabetes galectin3

Search results

Items: 1 to 20 of 119

1.

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

Hernández-Romero D, Vílchez JA, Lahoz Á, Romero-Aniorte AI, Jover E, García-Alberola A, Jara-Rubio R, Martínez CM, Valdés M, Marín F.

Sci Rep. 2017 Jan 12;7:40378. doi: 10.1038/srep40378.

2.

Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.

Holmager P, Egstrup M, Gustafsson I, Schou M, Dahl JS, Rasmussen LM, Møller JE, Tuxen C, Faber J, Kistorp C.

BMC Cardiovasc Disord. 2017 Jan 10;17(1):22. doi: 10.1186/s12872-016-0437-6.

3.

Diabetes: Turning down galectin 3 to combat insulin resistance.

Kingwell K.

Nat Rev Drug Discov. 2016 Dec 29;16(1):18. doi: 10.1038/nrd.2016.276. No abstract available.

PMID:
28031565
4.

Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?

Berezin AE.

Diabetes Metab Syndr. 2016 Dec 13. pii: S1871-4021(16)30284-3. doi: 10.1016/j.dsx.2016.12.032. [Epub ahead of print] Review.

PMID:
28011232
5.

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.

Pejnovic N, Jeftic I, Jovicic N, Arsenijevic N, Lukic ML.

World J Gastroenterol. 2016 Nov 28;22(44):9706-9717. Review.

6.

Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.

Derosa G, Maffioli P, D'Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Guasti L, Sarzani R, Bestetti A, Vanasia M, Gaudio G; ESCAPE-IT Trial Investigators group..

Cardiovasc Ther. 2017 Feb;35(1):47-54. doi: 10.1111/1755-5922.12235.

PMID:
27860389
7.

Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.

Li P, Liu S, Lu M, Bandyopadhyay G, Oh D, Imamura T, Johnson AM, Sears D, Shen Z, Cui B, Kong L, Hou S, Liang X, Iovino S, Watkins SM, Ying W, Osborn O, Wollam J, Brenner M, Olefsky JM.

Cell. 2016 Nov 3;167(4):973-984.e12. doi: 10.1016/j.cell.2016.10.025.

PMID:
27814523
8.

Impact of diabetes on the predictive value of heart failure biomarkers.

Alonso N, Lupón J, Barallat J, de Antonio M, Domingo M, Zamora E, Moliner P, Galán A, Santesmases J, Pastor C, Mauricio D, Bayes-Genis A.

Cardiovasc Diabetol. 2016 Nov 3;15(1):151.

9.
10.

Role of galectin-3 in autoimmune and non-autoimmune nephropathies.

Saccon F, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.

Autoimmun Rev. 2017 Jan;16(1):34-47. doi: 10.1016/j.autrev.2016.09.023. Review.

PMID:
27666815
11.

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities.

Musso G, Cassader M, Cohney S, De Michieli F, Pinach S, Saba F, Gambino R.

Diabetes Care. 2016 Oct;39(10):1830-45. doi: 10.2337/dc15-1182. Review.

PMID:
27660122
12.

Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study.

Begg GA, Lip GY, Plein S, Tayebjee MH.

Clin Biochem. 2017 Jan;50(1-2):11-15. doi: 10.1016/j.clinbiochem.2016.09.008.

PMID:
27622867
14.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014.

15.

Sflt-1 in heart failure: relation with disease severity and biomarkers.

Gruson D, Hermans MP, Ferracin B, Ahn SA, Rousseau MF.

Scand J Clin Lab Invest. 2016 Sep;76(5):411-6. doi: 10.1080/00365513.2016.1190863.

PMID:
27291567
16.

HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.

Piek A, Meijers WC, Schroten NF, Gansevoort RT, de Boer RA, Silljé HH.

J Card Fail. 2017 Jan;23(1):12-19. doi: 10.1016/j.cardfail.2016.05.002.

17.

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.

Martín-Reyes R, Franco-Peláez JA, Lorenzo Ó, González-Casaus ML, Pello AM, Aceña Á, Carda R, Martín-Ventura JL, Blanco-Colio L, Martín-Mariscal ML, Martínez-Milla J, Villa-Bellosta R, Piñero A, Navarro F, Egido J, Tuñón J.

PLoS One. 2016 May 12;11(5):e0152816. doi: 10.1371/journal.pone.0152816.

18.

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.

Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Gromenko EA.

EBioMedicine. 2016 Jan 20;4:86-94. doi: 10.1016/j.ebiom.2016.01.018.

19.

The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential.

Scandolera A, Odoul L, Salesse S, Guillot A, Blaise S, Kawecki C, Maurice P, El Btaouri H, Romier-Crouzet B, Martiny L, Debelle L, Duca L.

Front Pharmacol. 2016 Mar 4;7:32. doi: 10.3389/fphar.2016.00032. Review.

20.

Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.

Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 May 1;456:19-23. doi: 10.1016/j.cca.2016.02.014.

Items per page

Supplemental Content

Loading ...
Support Center